We are live on ! Find out more
VAXX

Vaxxinity, Inc. Class A Common Stock

Delisted

VAXX was delisted on the 8th of May, 2024.

0 hedge funds and large institutions have $0 invested in Vaxxinity, Inc. Class A Common Stock in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 80 (-8)

100% less capital invested

Capital invested by funds: $67.8K → $0 (-$67.8K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
Holders Change
-8
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SWM
1
Spire Wealth Management
Virginia
-$40.4K -161,776 Closed
XT
2
XTX Topco
Cayman Islands
-$16.7K -67,106 Closed
CGL
3
Clarius Group LLC
Washington
-$4.99K -20,000 Closed
GT
4
Glenmede Trust
Pennsylvania
-$4.78K -19,158 Closed
Osaic Holdings
5
Osaic Holdings
Arizona
-$596 -2,386 Closed
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$206 -825 Closed
RF
7
Robinswood Financial
Washington
-$13 -55 Closed

VAXX Hedge Fund Activity: Q3 2024 in Review

0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q3 2024, worth a combined $0 — down 100% from $67.8K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of VAXX and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Spire Wealth Management, exiting entirely with an estimated $40.4K sold.

  • 0 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q3 2024, down from 8 in Q2 2024.
  • Funds reported $0 of Vaxxinity, Inc. Class A Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q3 2024 and 8 closed out, a net change of -8 holders.
  • The largest Vaxxinity, Inc. Class A Common Stock seller in Q3 2024 was Spire Wealth Management, an estimated $40.4K sold.

Based on aggregated 13F filings for Q3 2024.